title: Progressive supranuclear palsy syndrome induced by clebopride.
abstract: We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP-like syndrome attributable to an antidopaminergic drug.
authors.affiliation: Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona, Spain.
authors.forename: Jaume
authors.initials: J
authors.lastname: Campdelacreu
authors.forename: Hatice
authors.initials: H
authors.lastname: Kumru
authors.forename: Eduard
authors.initials: E
authors.lastname: Tolosa
authors.forename: Josep
authors.initials: J
authors.lastname: Valls-Solé
authors.forename: Antoni
authors.initials: A
authors.lastname: Benabarre
mesh_terms: D000932:Antiemetics / Q000009:adverse effects*; D001549:Benzamides / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D013494:Supranuclear Palsy, Progressive / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000932:Antiemetics; D001549:Benzamides; C014417:clebopride